← Leaderboards
Wt Longstreth
University Of Washington
$6,269,140
Attributed
$25,703,465
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7M · FY2017–25$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,703,465 · 3
By mechanism
U01$21,995,212 · 1
R01$3,708,253 · 2
Top collaborators
- Joseph Paul Broderick5 shared
- Hooman Kamel5 shared
- Caitlyn N Meinzer5 shared
- David L Tirschwell5 shared
- Mitchell S Elkind4 shared
- Lin Yee Chen1 shared
- James S Floyd1 shared
- Randolph S Marshall1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Chun Yuan$11,768,740
- Mahmud Mossa-Basha$3,726,316
- David L Tirschwell$8,538,743
- Susan Heckbert$14,216,326
- Younghoon Kwon$4,506,335
Others in their field
Top investigators on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- David Heimbrook · Leidos Biomedical Research, Inc.$277,323,479
- Richard A Gibbs · Baylor College Of Medicine$249,395,936
- David R. Weir · University Of Michigan At Ann Arbor$236,797,614
- Peter B. Gilbert · Fred Hutchinson Cancer Center$153,633,436
- Ralph Parchment · Leidos Biomedical Research, Inc.$135,017,102
Research focus
ScreeningPrimary PreventionLeft Atrial StructureRisk FactorsTherapeutic TargetRandomizedHeart AtriumLeftPreventionRecurrenceClinical ResearchStrokeValidationBiological MarkersElectrocardiogramAspirinIschemic StrokeLeadAtrial FibrillationPreventArteriesArterial Fatty StreakChild (0-11)Cardiac
Grant awards (10)
Proteomic and Genomic Discovery of Targets for Atrial Cardiopathy-Related Cardiovascular Outcomes$1,657,473
R01 · FY2025 · HL
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$2,310,548
U01 · FY2022 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$1,790,846
U01 · FY2021 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,861,083
U01 · FY2020 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,959,908
U01 · FY2018 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$4,072,827
U01 · FY2017 · NS
EPIDEMIOLOGY OF NARCOLEPSY$378,632
R01 · FY2004 · NS
EPIDEMIOLOGY OF NARCOLEPSY$591,187
R01 · FY2003 · NS
EPIDEMIOLOGY OF NARCOLEPSY$566,112
R01 · FY2002 · NS
EPIDEMIOLOGY OF NARCOLEPSY$514,849
R01 · FY2001 · NS